Ruth Pidsley

机构：New South Wales Department of Health, Garvan Institute of Medical Research, UNSW Sydney, St Vincent's Clinic · ORCID：0000-0002-1386-1374

发表论文 86 篇 · 总被引 8692 次 · h-index 30

代表论文

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer (2023 · Nature Cancer · 被引 133)
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling (2024 · BMC Genomics · 被引 62)
Advances in Prognostic Methylation Biomarkers for Prostate Cancer (2020 · Cancers · 被引 36)
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer (2024 · Nature Structural & Molecular Biology · 被引 34)
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer (2021 · Clinical Epigenetics · 被引 33)
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer (2020 · Clinical Epigenetics · 被引 31)